Boyce J, Eisenbarth S
J Clin Invest. 2025; 134(12).
PMID: 40047886
PMC: 11178525.
DOI: 10.1172/JCI182410.
Schwarz E, Jebbawi F, Keller G, Rhiner T, Fricker A, Waldern N
Vet Sci. 2024; 11(10).
PMID: 39453068
PMC: 11512288.
DOI: 10.3390/vetsci11100476.
Orlando P, Vivarelli E, Minzoni A, Licci G, Accinno M, Brugnoli B
Eur Arch Otorhinolaryngol. 2024; 282(1):265-272.
PMID: 39404884
PMC: 11735555.
DOI: 10.1007/s00405-024-09027-8.
Xie L, Zhang H, Xu L
Cell Mol Gastroenterol Hepatol. 2024; 19(2):101413.
PMID: 39349246
PMC: 11719855.
DOI: 10.1016/j.jcmgh.2024.101413.
Stanziola A, Candia C, Nazzaro G, Caso A, Merola C, Gallotti L
Front Pharmacol. 2024; 15:1449220.
PMID: 39175541
PMC: 11338755.
DOI: 10.3389/fphar.2024.1449220.
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease.
Arnold I, Munitz A
Nat Rev Immunol. 2024; 24(12):858-877.
PMID: 38982311
DOI: 10.1038/s41577-024-01048-y.
A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective.
Motataianu A, Andone S, Stoian A, Balasa R, Hutanu A, Sarmasan E
Int J Mol Sci. 2024; 25(7).
PMID: 38612591
PMC: 11011909.
DOI: 10.3390/ijms25073782.
Protective effect of Achyranthes aspera against compound 48/80, histamine and ovalbumin-induced allergic disorders in murine model.
Kaushik A, Singh D, Sahu M, Kumar A, Pratibha , Pandey P
Mol Biol Rep. 2024; 51(1):202.
PMID: 38270668
DOI: 10.1007/s11033-023-09137-2.
Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms?.
Crocetto F, Imbimbo C, Barone B, Turchino D, Bracale U, Peluso A
Basic Clin Androl. 2023; 33(1):38.
PMID: 38110896
PMC: 10729439.
DOI: 10.1186/s12610-023-00213-y.
Successful immunosuppressant-free treatment of a drug-induced sarcoidosis-like reaction caused by dupilumab.
Saito S, Shimizu M, Miyashita R, Inoue T, Nagano A, Kunugi S
Respir Med Case Rep. 2023; 44:101883.
PMID: 37305219
PMC: 10249011.
DOI: 10.1016/j.rmcr.2023.101883.
Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases.
Gao J, Xia Z, Vohidova D, Joseph J, Luo J, Joshi N
Acta Pharm Sin B. 2023; 13(4):1400-1428.
PMID: 37139423
PMC: 10150162.
DOI: 10.1016/j.apsb.2022.07.010.
Pilot Biomarker Analysis and Decision Tree Algorithm Modeling of Patients with Chronic Subdural Hematomas.
Puccio D, Deng H, Eagle S, Okonkwo D, Nwachuku E
Neurotrauma Rep. 2023; 4(1):184-196.
PMID: 36974123
PMC: 10039273.
DOI: 10.1089/neur.2022.0062.
JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang I, Chung W, Wu P, Chen C
Front Immunol. 2022; 13:1068260.
PMID: 36569854
PMC: 9773077.
DOI: 10.3389/fimmu.2022.1068260.
Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.
Ceulemans M, Jacobs I, Wauters L, Vanuytsel T
Front Neurosci. 2022; 16:831761.
PMID: 35557605
PMC: 9087267.
DOI: 10.3389/fnins.2022.831761.
Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media.
Chikumoto A, Oishi K, Hamada K, Hirano T, Kakugawa T, Kanesada K
Biomolecules. 2022; 12(4).
PMID: 35454111
PMC: 9025540.
DOI: 10.3390/biom12040522.
Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls.
Zhan C, Xu R, Li B, Liu J, Liang W, Zhang S
Front Immunol. 2022; 13:737968.
PMID: 35432356
PMC: 9009386.
DOI: 10.3389/fimmu.2022.737968.
A pragmatic guide to choosing biologic therapies in severe asthma.
Kavanagh J, Hearn A, Jackson D
Breathe (Sheff). 2022; 17(4):210144.
PMID: 35296105
PMC: 8919802.
DOI: 10.1183/20734735.0144-2021.
Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone.
Lachance M, Bernard J, Lavoie A, Gagne E, Grenier P
JAAD Case Rep. 2022; 22:11-13.
PMID: 35265739
PMC: 8899130.
DOI: 10.1016/j.jdcr.2022.01.022.
Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4CD25 Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.
Hall B, Hall R, Tran G, Robinson C, Wilcox P, Rakesh P
Front Immunol. 2021; 12:714838.
PMID: 34912327
PMC: 8667344.
DOI: 10.3389/fimmu.2021.714838.
Evaluating prognostic value and relevant gene signatures of tumor microenvironment characterization in esophageal carcinoma.
Sheng W, Li X, Li J, Mi Y, Li F
J Gastrointest Oncol. 2021; 12(4):1228-1240.
PMID: 34532083
PMC: 8421893.
DOI: 10.21037/jgo-21-371.
